Stablepoint Partners’s Lam Research LRCX Stock Holding History

Stablepoint Partners’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$443K	Sell	1,022 -11	-1%	-$3.34K	0.06%	200
2026 Q1	$221K	Buy	+1,033	New	+$231K	0.03%	250

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stablepoint Partners's LRCX Position: Q2 2026 in Review

Stablepoint Partners reduced its Lam Research (LRCX) stake by 1.1% in Q2 2026, selling an estimated $3.34K and leaving 1,022 shares worth $443K. The position accounts for 0.06% of the portfolio, ranked #200.

Stablepoint Partners first reported a position in LRCX in Q1 2026 and has held it in 2 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Stablepoint Partners held 1,022 shares of Lam Research worth $443K as of Q2 2026.
Stablepoint Partners sold 11 Lam Research shares in Q2 2026, an estimated $3.34K.
Lam Research made up 0.06% of Stablepoint Partners's portfolio in Q2 2026, its #200 holding.
Stablepoint Partners first reported a position in Lam Research in Q1 2026 and has held it in 2 quarters since.
3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.